cancer vaccine
Clinical trials for personalised cancer vaccine used to tackle aggressive brain tumours in young adults and adolescents launched by UCLA Health
August 6, 2024Research and Development Oncology, UCLA Health, adolescent cancer, brain tumour, cancer vaccine, clinical trial
Today, researchers at the UCLA Health Jonsson Comprehensive Cancer Center have announced that they are launching a first-of-its-kind clinical trial to …
Boehringer pays $600m for cancer vaccine deal
September 19, 2014Research and Development, Sales and Marketing Boehringer Ingelheim, cancer vaccine, oncology, pd1
Boehringer is hoping to expand its oncology pipeline with a new multi-million dollar pact for an investigational cancer vaccine. The …
Pfizer to develop phase II cancer vaccine
September 4, 2012Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine
Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
BMS launches skin cancer treatment Yervoy in UK
August 22, 2011Sales and Marketing Yervoy, cancer vaccine, ipilimumab, skin cancer
Bristol-Myers Squibb’s skin cancer treatment Yervoy has been launched in the UK for patients with the deadliest form of the …
BMS skin cancer vaccine hits phase III target
March 23, 2011Research and Development BMS, Bristol-Myers Squibb, advanced inoperable skin cancer, advanced melanoma, cancer drugs, cancer vaccine, ipilimumab
Bristol Myers Squibb’s cancer vaccine ipilimumab has increased overall survival in advanced melanoma patients. The therapy was being tested as …
Amgen signs $1 billion cancer biotech deal
January 25, 2011Research and Development Amgen, BioVex, OncoVEXGM-CSF, cancer vaccine
Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …
Dendreon will outsource first Provenge production in EU
January 11, 2011Manufacturing and Production Dendreon, Provenge, cancer vaccine, contract manufacturing, sipuleucel-T, vaccine manufacturing, vaccines
US oncology specialist Dendreon has decided to hire a contract manufacturer for its cell-based cancer therapy Provenge in Europe to …
Dendreon eyes late 2011 European cancer vaccine filing
January 10, 2011Sales and Marketing Cancer, Denreon, Provenge, cancer vaccine, sipuleucel, vaccines
Dendreon Group is to seek marketing authorisation in Europe for the world’s first immunotherapy cancer vaccine in late 2011 or …
Bavarian Nordic courting cancer vaccine backers
November 12, 2010Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan
Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …
Transgene acquires rights to cancer vaccine
September 10, 2010Research and Development JX-594, Jennerex, Transgene, cancer vaccine
French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
Pfizer drops brain cancer vaccine
September 7, 2010Research and Development Celldex Therapeutics, Pfizer, cancer vaccine
Pfizer has dropped its experimental brain cancer vaccine rindopepimut, handing back worldwide rights to Celldex Therapeutics from November. Rindopepimut targets …
Lung cancer vaccine poised to begin phase IIb/III trials
September 1, 2010Research and Development NSCLC, TG4010, Transgene, cancer vaccine
French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …
Trials of cancer vaccine Stimuvax can resume
June 17, 2010Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines
Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
